Evidence map›Paper›PMID 28589171›Full record

ArticleData in brief2017

Microarray dataset of transient and permanent DNA methylation changes in HeLa cells undergoing inorganic arsenic-mediated epithelial-to-mesenchymal transition.

Meredith Eckstein, Matthew Rea, Yvonne N Fondufe-Mittendorf

Open access · goldAbstract read
In one paragraph

Article in Data in brief, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Meredith EcksteinUniversity of Kentucky Department of Molecular and Cellular Biochemistry, United States.
Matthew ReaUniversity of Kentucky Department of Molecular and Cellular Biochemistry, United States.
Yvonne N Fondufe-MittendorfUniversity of Kentucky Department of Molecular and Cellular Biochemistry, United States.
University of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variantsR01ES034253 · NIEHS · VAN ANDEL RESEARCH INSTITUTE · PI Yvonne Nsokika Fondufe-Mittendorf · 2022 to 2026
$3.3M
Interdisciplinary Research Training in Cancer BiologyT32CA165990 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers, KATHLEEN L. O'CONNOR · 2013 to 2026
$3.2M
Molecular Underpinnings in the Establishment of an Oncogenic 3D Genome inResponse to Environmental Arsenic ExposureR01ES031846 · NIEHS · VAN ANDEL RESEARCH INSTITUTE · PI FONDUFE-MITTENDORF, YVONNE NSOKIKA · 2020 to 2024
$2.7M
The role of chromatin structural and epigenetic changes in arsenic-induced gene expressionR01ES024478 · NIEHS · UNIVERSITY OF KENTUCKY · PI FONDUFE-MITTENDORF, YVONNE NSOKIKA · 2015 to 2019
$1.8M
NCI NIH HHS P30 CA177558NCI NIH HHS T32 CA165990NIEHS NIH HHS R01 ES024478NIEHS NIH HHS R01 ES031846NIEHS NIH HHS R01 ES034253
6 · The paper itself

Abstract

The novel dataset presented here represents the results of the changing pattern of DNA methylation profiles in HeLa cells exposed to chronic low dose (0.5 µM) sodium arsenite, resulting in epithelial-to-mesenchymal transition, as well as DNA methylation patterns in cells where inorganic arsenic has been removed. Inorganic arsenic is a known carcinogen, though not mutagenic. Several mechanisms have been proposed as to how inorganic arsenic drives carcinogenesis such as regulation of the cell׳s redox potential and/or epigenetics. In fact, there are gene specific studies and limited genome-wide studies that have implicated epigenetic factors such as DNA methylation in inorganic arsenic-mediated epithelial-to-mesenchymal transition (EMT). However, genome-wide studies about the impact of 1) chronic, low-dose inorganic arsenic exposure on DNA methylation patterns during inorganic arsenic-induced epithelial-to-mesenchymal transition, and 2) the removal inorganic arsenic (reversal) on DNA methylation patterns, is lacking. For this dataset, two replicates were performed with each of the samples - non-treated, inorganic arsenic-treated, and reverse-treated cells. We provide normalized and processed data, and log2 fold change in DNA methylation. The raw microarray data are available through NCBI GEO, accession number GSE95232 and a related research paper has been accepted for published in Toxicology and Applied Pharmacology (Eckstein et al., 2017) [1].

Indexed as

DNA methylationEpigeneticsEpithelial-to-mesenchymal transitionInfinium Methylation EPIC Bead-ChipInorganic arsenic

Identifiers

PMID28589171
PMCPMC5443927
OpenAlexW2612818922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.